Description:

The National Director, Medical Science Liaison Team, will participate in the strategy development for all pipeline products and provide oversight and direction to the Field Medical Science Liaison team. This key player-coach role will report into the Vice-President, Medical Affairs and be accountable for the attainment of US medical and business objectives appropriate to a Medical Affairs organization. As part of the US Medical Leadership team and in partnership with Clinical Development and the integrated US Brand team, develop and implement strategic field initiatives and tactics to support the therapeutic area medical objectives, the coordination and optimization of materials, and the communications to execute field activities. The role is responsible for establishing and maintaining professional relationships with thought leaders and Key Opinion Leaders (KOLs), external healthcare customers, and key internal colleagues to communicate scientific and clinical information. The position will create and maintain metrics and lead key strategic, cross-functional projects.

The successful candidate will have demonstrated effective people-management skills, an organized approach to prioritization, a flexible and adaptable work style, an openness to creativity, and a documented history of delivering successful results on time.

Key Duties and Responsibilities:

  • Recruit, hire, and retain a qualified, highly motivated, diverse-thinking, and flexible MSL team
  • Oversee and ensure the highest medical and scientific standard and expertise across the MSL team; develop a standard of professionalism that demonstrates the highest regard for established regulatory and legal compliance in accordance with company policies and sound ethical practices
  • Actively manage the MSL team by encouraging professional and personal development; lead by example and nurture individual growth, thereby optimizing team performance
  • Support and train the team in engaging in compliant scientific exchange about current and emerging therapies, discussions around investigator-initiated trials, and in delivering effective presentations; provide appropriate mentoring and coaching to direct reports with respect to technical skills, business acumen/planning, and effective regional and time management, including frequent field visits with the MSL team
  • Work with Medical Affairs leadership and medical directors to define strategic initiatives; communicate clearly and frequently to the MSL team and ensure alignment with medical affairs and corporate initiatives
  • Be an active player-coach in supporting the MSL team with the identification and maintenance of relationships with national, regional and local medical and scientific key opinion leaders (KOLs)
  • Work creatively with Medical Affairs leadership to develop meaningful, measurable key performance measures to assess and track the success of the MSL team and function and report metrics to Medical Affairs leadership on a regular basis; ensure that goals/performance/ development plans are reviewed on at least a quarterly basis; conducts annual and mid-year performance reviews; create and encourage an environment that stresses open, candid, and timely feedback relative to performance
  • Provide ongoing field updates and insights, including competitive intelligence, and synthesize this information into meaningful, actionable imperatives
  • Participate in the development and execution of Medical Affairs activities, such Advisory Boards, Speaker Training, and development of scientific and medical presentation slides
  • Provide medical support to cross-functional partners (Marketing, Training, Market Access, Clinical Development)
  • Develop and maintain scientific, clinical and therapeutic expertise in relevant disease states; develop and deliver medical presentations to both internal and external stakeholders
  • Develop, assign and manage specific projects within the MSL team, such as medical review of the AMCP Dossier, competitor clinical trial progress, and MSL training
  • Demonstrate the ability and desire to work collaboratively, respectfully, and creatively with diverse stakeholders, including leadership and within the MSL team
  • Create, execute and maintain SOPs and guidance for the MSL function
  • Manage the overall MSL budget and administrative aspects of the team
  • Other duties as needed

Education, Skills and Experience:

  • Doctoral degree (PhD, PharmD, MD or DO) required
  • Minimum of 5 years of experience as an MSL in industry; at least 2 years of experience managing an MSL team
  • Minimum of 3 years of experience in hematology or oncology
  • A well-established KOL hematology/oncology network is strongly preferred
  • Proven track record of success in establishing and maintaining thought leader relationships, territory planning, and integration with other field roles
  • Strong understanding of industry and regulatory guidelines pertinent to compliant interactions with external audiences
  • Demonstrated ability to comprehend complex scientific, medical, and relevant business issues and respond with actionable strategies and tactics to effectively produce timely and measurable results
  • Successful record of managing large and complex projects with minimal oversight
  • Strong interpersonal and communication skills, both oral and written
  • Excellent ability in searching and interpreting medical literature
  • Estimated travel ~50-60%

About AVEO

AVEO Oncology (AVEO) is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted therapeutics for oncology and other areas of unmet medical need. The Company is focused on seeking to develop and commercialize its lead candidate tivozanib, a potent, selective, long half-life inhibitor of vascular endothelial growth factor 1, 2 and 3 receptors, in North America as a treatment for renal cell carcinoma and other cancers. AVEO is leveraging multiple partnerships aimed at developing and commercializing tivozanib in oncology indications outside of North America, and at progressing its pipeline of novel therapeutic candidates in cancer and cachexia (wasting syndrome). Tivozanib (FOTIVDA®) is approved by the European Commission for the treatment of adult patients with advanced renal cell carcinoma (RCC) in the European Union plus Norway and Iceland.

Apply Now